Pentylenetetrazole (PTZ) is a widely-used convulsant used in studies of epilepsy; its subcutaneous injection generates an animal model with stable seizures. Here, we compared the ability of PTZ via the intravenous and subcutaneous routes to evoke progressive epileptiform activity in the hippocampal CA1 neurons of anesthetized rats. The involvement of the BDNF-TrkB pathway was then investigated. When PTZ was given intravenously, it induced epileptiform bursting activity at a short latency in a dose-dependent manner. However, when PTZ was given subcutaneously, it induced a slowly-developing pattern of epileptogenesis; first, generating multiple population-spike peaks, then spontaneous interictal discharge-like spike, leading to the final ictal discharge-like, highly synchronized bursting fi ring in the CA1 pyramidal layer of the hippocampus. K252a, a TrkB receptor antagonist, when given by intracerebroventricular injection, signifi cantly reduced the probability of multiple population spike peaks induced by subcutaneous injection of PTZ, delayed the latency of spontaneous spikes, and reduced the burst frequency. Our results indicate that PTZ induces a progressive change of neuronal epileptiform activity in the hippocampus, and the BDNF-TrkB signaling pathway is mainly involved in the early phases of epileptogenesis, but not the synchronized neuronal burst activity associated with epileptic seizure in the PTZ animal model. These results provide basic insights into the changing pattern of hippocampal neuronal activity during the development of the PTZ seizure model, and establish an in vivo seizure model useful for future electrophysiological studies of epilepsy.
INTRODUCTION
In the central nervous system, pentylenetetrazole (PTZ) acts as a cerebral stimulant; it counteracts the action of the γ-aminobutyric acid type A (GABA A ) receptor by interacting with the picrotoxin-barbiturate binding site, closing Cl − channels, thereby interfering with GABA A receptors and provoking seizures [1] . Despite the fact that PTZ has been widely used to induce seizures in rodent models in epilepsy studies [2, 3] , the mechanisms underlying PTZ-induced epileptogenesis are still not fully understood.
Brain-derived neurotrophic factor (BDNF) is a small dimeric protein belonging to the nerve growth factor family of neurotrophins, and is widely expressed in several areas of the adult brain, including the hippocampus [4, 5] .
BDNF is mainly secreted by astrocytes [6] , while neuronal Neurosci Bull October 1, 2013, 29(5): 565-575 566 activity affects BDNF release [7, 8] . Studies have shown that BDNF plays a key role in epileptogenesis [9] [10] [11] [12] . It binds to TrkB receptors and activates down-stream protein kinases to phosphorylate substrates, inducing an increased presynaptic release probability or changes in the postsynaptic functions of receptor such as the GABA A receptor [5, 13] . Neurons are also directly depolarized or fi re action potentials with rapid application of BDNF [13, 14] . In addition, epileptiform activity increases the expression levels of both BDNF mRNA and protein [15] [16] [17] . Early transgenic study showed that, in BDNF-heterozygous mice, compared to the wild-type controls, the kindling rate of the epilepsy was decreased by two-fold [18] . Moreover, a recent study showed that when the TrkB receptor is knocked out (but not BDNF itself), the epileptiform activity in the kindling model of epilepsy is suppressed [19] .
Our previous in vivo electrophysiological study also demonstrated that blockade of TrkB receptors inhibits epileptogenesis in an animal model with cyclothiazideinduced seizures [20] . Thus, these results suggest that BDNF-TrkB signaling is pro-epileptic [16, 17, 21] .
Animal models of seizures, including those induced by kindling, kainic acid (KA), pilocarpine, and cyclothiazide, have all shown an association with the BDNF-TrkB signaling pathway [20, [22] [23] [24] [25] . However, the role of the BDNF-TrkB signaling pathway in PTZ-induced seizures is still not clear.
Early studies showed that PTZ causes epileptic seizures and changes the expression of BDNF mRNA and protein, while other experiments suggested that PTZ does not alter the level of BDNF protein [26, 27] . Thus, it is worthwhile to further study the involvement of the BDNF-TrkB signaling pathway in the PTZ model.
Hippocampal neurons play a key role in epileptogenesis, particularly in temporal lobe epilepsy [28] , and hippocampal neuronal electrical activity has a tight relationship with epileptogenesis [29] . However, little is known about the direct effect of PTZ on hippocampal neuronal activity in intact animals. In the current study, the anesthetized rats were used to first compare the effects of PTZ, given either intravenously (i.v.) or subcutaneously (s.c.), on the activity of hippocampal CA1 pyramidal neurons, and the involvement of the BDNF-TrkB signaling pathway in PTZinduced epileptogenesis was investigated.
MATERIALS AND METHODS

Drugs and Solutions
The following drugs were freshly made before each experiment: pentylenetetrazole salt in 1 mL distilled water and K252a in DMSO for intracerebroventricular (i.c.v.) injection (from Tocris, Northpoint, Bristol); and urethane (25%; Sigma Aldrich Chemical Co., Poole, UK) was dissolved in distilled water.
Animal Preparation
All experiments were carried out in urethane-anesthetized The rats were prepared as previously described [20, 29, 30] .
Briefl y, rats were fi rst anesthetized with urethane (1.2 g/kg, s.c.). The absence of a withdrawal refl ex was used to judge the anesthesia level during the whole experimental period, and additional anesthetic (urethane, 0.2-0.6 mg/kg, s.c.)
was administered when necessary. During the experiment, body temperature was maintained at 37.0 ± 0.5°C with a heating blanket (Harvard Apparatus Limited, Edenbridge, UK). In order to expose the top part of the skull, an incision was made in the midline of the head after the animal was mounted in a stereotaxic frame. Ltd., Sevenoaks, UK), pre-cut to extend 4 mm below the surface, was then placed into the drilled hole for later i.c.v.
drug delivery, and secured with the dental cement.
Recording and Data Acquisition
To insert the recording and stimulating electrodes, a large burr hole was drilled in the left side of the skull above the hippocampal area. Both the dura and pia were then pierced and removed. The electrode positions were determined according to the stereotaxic atlas of the rat brain [31] . A pyramidal neurons [32] .
Data Analysis
The recorded electrophysiological signals were analyzed offline using the Spike2 program (Cambridge Electronic Design). Since the PS peaks typically represent epileptiform evoked responses [29] the latency for evoking the second and third PS peaks was calculated and analyzed. Spiking events were defined as being spontaneously-generated with high amplitude (>0.5 mV) and containing one or two spikes occurring at a low frequency (<1 Hz). The latency for these spikes was analyzed from the usual 'silent' baseline.
Highly-synchronized bursting activity was defined, in distinguishing from spontaneous spiking events, as having high-frequency multiple high-amplitude spikes (>0.5 mV)
with an initial inter-spike interval of <0.2 s, a minimum of 5 spikes, and a burst duration >1 s, as previously reported.
Group data are presented as mean ± SEM. Across the data groups, statistical significance between means was determined using one-way ANOVA with Tukey HSD post hoc analysis (GraphPad Prism, GraphPad Software Inc., San Diego, CA). Comparisons within a group used the twotailed t-test. Signifi cance level was set at P <0.05.
RESULTS
Intravenous PTZ Induced Epileptiform Bursting Activity in CA1 Pyramidal Neurons of Anesthetized Rats in a Dose-dependent Manner
In a previous study, we demonstrated that s.c. injection of PTZ at a high dose induced progressive epileptiform activity in the CA1 pyramidal layer [3] , but not i.c.v. injection. Here we fi rst studied the epileptiform bursting activity induced in the CA1 pyramidal layer of anesthetized rats after bolus i.v.
injection of PTZ.
Intravenous injection of saline did not induce any change on the baseline firing. However, i.v. injection of cumulative PTZ at doses of 55, 110 and 220 mg/ kg dose-dependently evoked epileptiform burst activity in hippocampal CA1 neurons (Fig. 1) . In total of eight rats tested, 25% (1/8), 75% (6/8) and 100% (8/8) of rats were induced to exhibit epileptiform burst(s) when PTZ was given at cumulative doses of 55, 110 and 220 mg/ kg, respectively (Fig. 1Ba) . Intravenous PTZ-induced bursting activity occurred normally in a very short latency, even during the drug injection period (50 s) (Fig. 1A) . The average evoked burst numbers (within 1-h recording time)
were 0.4 ± 0.2 (n = 8), 1.5 ± 0.7 (n = 8) and 10.6 ± 2.0 (n = 8), at the doses of 55, 110 and 220 mg/kg, respectively (Fig.   1Bb ). The corresponding burst frequencies were 0.0030 ± 0.0003 Hz (n = 3) at 110 mg/kg and 0.0054 ± 0.0007 Hz (n = 8) at 220 mg/kg (Fig. 1Bc) . Further statistical analysis showed that the high dose of PTZ (220 mg/kg, i.v.) evoked more epileptiform bursts and a higher bursting frequency in hippocampal CA1 neurons (P <0.01) (Fig. 1B) .
Subcutaneous PTZ Induced Progressive Epileptogenesis in CA1 Pyramidal Neurons in Anesthetized Rats in a Dose-dependent Manner
A previous study demonstrated that s.c. PTZ at 383 mg/kg induces epileptiform burst activity in anesthetized rats [3] .
We therefore investigated the dose-dependent effect of s.c.
PTZ on the induction of progressive epileptogenesis in the CA1 pyramidal layer.
In anesthetized rats, recordings were made from the CA1 pyramidal cell layer while stimulating the CA3 area once every 60 s. In the control condition, a downward single PS peak normally appeared on the upward evoked EPSP and there was no spontaneous activity ( Fig. 2Aa, Ba) . PTZ at doses of 55, 165 and 550 mg/kg (s.c.) dose-dependently induced progressive epileptiform activity, similar to a previous study in the cyclothiazide-induced epilepsy model [30] . First, PTZ dose-dependently induced multiple PS peaks in the stimulus-evoked EPSP-PS complex fi eld potential in CA1 pyramidal neurons in a time-dependent manner ( Fig. 2Ab, c) . At all three doses tested, a second PS-peak was induced in all rats tested at latencies of 60.6 ± 7.3 (55 mg/kg; n = 5), 11.7 ± 0.8 (165 mg/kg; n = 7) and 8.2 ± 1.1 min (550 mg/kg; n = 5). The latency for the second peak showed signifi cant dose-dependent decreases (P <0.05 to P < 0.001; Fig. 3Ab ). The third peak was induced only in 1 out of 5 rats when PTZ was applied at 55 mg/kg dose, but was induced in all rats tested with PTZ at 165 and 550 mg/kg doses (Fig. 3Aa) . The latencies were 24.7 ± 6.3 (n = 7) and 22.8 ± 2.3 min (n = 5) for PTZ doses of 165 and 550 mg/kg, respectively, and they were not statistically different (Fig. 3Ab) . The second events following PTZ injection were spontaneous high-amplitude spikes, which were induced in all rats at all 3 doses of PTZ (Fig.   3Ba ). The latencies for these spontaneous high-amplitude spikes were 103.6 ± 4.3 (n = 5), 41.2 ± 3.3 (n = 7) and 6.4 ± 2.9 min (n = 5), respectively, for PTZ doses of 55, 165
and 550 mg/kg. The differences in the latencies for these spikes showed signifi cant dose-dependent decreases (Fig.   3Bb ). The fi nal events following PTZ injection were highly synchronized bursts. The burst activity was induced only by PTZ at doses of 165 mg/kg (6/7 rats) and 550 mg/kg (5/5 rats) (Fig. 3Ba) . The latencies for inducing synchronized epileptiform bursts were 65.3 ± 4.6 min (165 mg/kg; n = 6) and 32.8 ± 3.8 min (550 mg/kg; n = 5) (Fig. 3Bb) , a significant dose-dependent decrease. Then we further analyzed the physical properties of the bursts at PTZ doses of 165 and 550 mg/kg, both of which induced epileptiform bursts. The number of bursts during the 3-h recording period after PTZ injection increased dose-dependently, 42 ± 10 (n = 6) at 165 mg/kg, and 96 ± 15 (n = 5) at 550 mg/kg (Fig. 3Ca) .
However, the burst frequency did not differ between 165 and 550 mg/kg PTZ. The mean epileptiform burst frequencies were 0.0064 ± 0.0028 Hz (n = 6) and 0.0082 ± 0.0022 Hz (n = 5), respectively for PTZ doses of 165 and 550 mg/kg (Fig. 3Cb) . This progressive pattern of epileptogenesis in hippocampal neurons after PTZ injection is similar to those reported in the cyclothiazide-induced epilepsy model [30] .
Effect of K252a on PTZ-induced Epileptiform Activity in
CA1 Pyramidal Neurons
In order to determine the involvement of the BDNF-TrkB 
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K252a pretreatment for 60 min significantly delayed the onset latency of the second and third evoked peaks from 11.7 ± 0.8 min (n = 7) to 30.6 ± 3.8 min (n = 5, P <0.01) and 24.7 ± 6.3 min (n = 7) to 57.6 ± 8.3 min (n = 5, P <0.05); however, K252a pretreatment for 30 min had no effect on either of these peaks (Fig. 4Ab) . In addition, K252a pretreatment for either 30 or 60 min also signifi cantly delayed the onset latency to spontaneous highamplitude spikes induced by PTZ (165 mg/kg, s.c.) from 41.2 ± 3.3 min (n = 6) to 53 ± 2.2 min (n = 5, P <0.01) and 58.8 ± 4.9 min (n = 4, P <0.05), respectively. In contrast, pretreatment with K252a for either 30 or 60 min had no effect on the latency for the burst occurrence and the total burst number (Fig. 4Bb, Ca) . However, K252a pretreatment for 60 min, but not for 30 min, signifi cantly suppressed the burst frequency from 0.0092 ± 0.0016 Hz (n = 6) to 0.0035 ± 0.0005 Hz (n = 4, P <0.05). These results indicate that K252a, a TrkB receptor inhibitor, has a suppressive effect PTZ is widely used to generate seizure animal models for epilepsy studies [2, 3] , which have shown that PTZ-kindling in rats induces moderate neuronal loss in hippocampal CA1, CA3, CA4 and the dentate gyrus [3, 33] , and increases the proliferation of granule cell precursors in the adult brain [34] . A PTZ-induced generalized seizure in immature rats provokes endogenous ACh-induced interictal-like discharges in adult hippocampal CA3 [35] . An in vitro study also showed that perfusion of cell cultures with PTZ (10 mmol/L) results in the generation of ictal-like epileptiform activity [36] . Our previous in vivo study also preliminarily showed that systemic (s.c.) application of PTZ induces epileptiform activities in the hippocampus [3] . In the current study, we used in vivo electrophysiological techniques to record hippocampal CA1 neuronal activity when PTZ was given either i.v. or s.c. Our results demonstrated that PTZ had dose-dependent effects on the induction of epileptiform activity in CA1 hippocampal neurons in anesthetized rats. When either saline or a low dose of PTZ (55 mg/kg) was injected i.v., no epileptiform activity was evoked. However, when the PTZ dose was increased to 110 and 220 mg/kg, the hippocampal neurons exhibited bursting activity at a very short latency. In contrast, when PTZ was given s.c., the burst activity had a long latency to the initiation of stimulus-evoked PS peak transformation [20, 30] : an initial transformation of the stimulus-evoked PS from a single peak to epileptiform multiple peaks, and then the occurrence of interictal-like high-amplitude spontaneous spike fi ring, to the fi nal ictallike highly-synchronized bursting. It should be noted that the current study was performed using the anesthetized animal, in which the anesthetic would affect the response to convulsant stimulation. Thus, the dose of the convulsant used to evoke the epileptiform activity and the latency of the neurons to respond to the convulsant stimulation per se were certainly different from those of animals in a conscious state. Indeed, our previous studies on cyclothiazideinduced seizures showed that the doses needed to evoke epileptic seizures in awake rats (Racine score III and above as well as bursting EEG) were much lower than those in anesthetized rats (hippocampal bursting activity) [20, 29] .
However, since in the current study we compared the response patterns of hippocampal neurons to the PTZ administered by either the i.v. or s.c. route, and then studied the effect of blockade of the BDNF-TrkB signaling pathway on the PTZ-induced epileptic activity, we believe that use of the anesthetized rats, as in a previous study [29] , did not affect the conclusions drawn from the results.
In this study, our results demonstrated that, when the animals were given PTZ by s.c. injection, 100% of the rats showed, at the fi rst stage, multiple peaks of the PS, a traditional determinant of epileptogenesis. Spontaneous epileptic seizure-like bursts occurred in 100% of the rats given either 165 or 550 mg/kg PTZ at a relatively long latency. Such ictal-like activity was composed of highamplitude and high-frequency synchronized bursting, similar to both the cyclothiazide and KA models [3, 20] as well as human temporal lobe epilepsy [37, 38] . Between the the evoked response change and the spontaneous bursting Indeed, in our current experiment, low dose of PTZ (55 mg/kg) only evoked spontaneous interictal-like spike activity, but no transformation to bursting (at least in our 3-h recording period), further supporting the notion that the formation of epileptiform bursts depends on an activity threshold. Once the threshold is exceeded, the network activity is synchronized. The reason for the network activity to surpass the threshold for inducing ictal-like bursting activity remains to be investigated.
BDNF is a secreted protein [39] that, in human, is encoded by the BDNF gene [40, 41] , which belongs to the neurotrophin family of growth factors. BDNF plays important roles in the CNS: promoting the growth and differentiation of new neurons and synapses, supporting the survival of existing neurons [42, 43] , and enhancing hippocampal learning and memory [44, 45] . BDNF binds to at least two receptors, TrkB and TrkA, on the surface of cells capable of responding to it [46] . BDNF-TrkB signaling is likely a common pathway involved in many different epilepsy models [9] , including KA, kindling, pilocarpine and cyclothiazide models [20, [22] [23] [24] [25] . BDNF potentiates glutamatergic neurotransmission as well as inhibiting GABAergic neurotransmission [47, 48] . Thus, the excessive activity evoked by a convulsant, such as PTZ, may induce BDNF release to further enhance neuronal excitability and thus promote the occurrence of epilepsy.
However, previous results on the relationship between BDNF and PTZ are contradictory. Some studies showed that PTZ-induced seizures strongly increase BDNF mRNA levels without corresponding increases of the protein [27] .
Other studies showed that in a PTZ model, astrocytes may participate in epilepsy through a marked but transient decrease in BDNF expression [26] . Thus, the relationship between BDNF and PTZ is unclear. In the current study, in the cyclothiazide model [20] . Cyclothiazide is a dualaction convulsant acting by enhancing AMPA receptor transmission and inhibiting GABA A receptor function, while PTZ mainly acts as a GABA A receptor inhibitor [1, 20] . This may explain the different involvement of the BDNF-TrkB signaling pathway in these two seizure models.
In conclusion, we demonstrated here that PTZ stimulates hippocampal neuronal epileptogenesis initially by evoking multiple PS peaks, towards spontaneous highamplitude spike fi ring and to the fi nal highly-synchronized burst fi ring a time-dependent manner, and that the BDNFTrkB signaling pathway is involved in this PTZ-induced progressive change of neuronal epileptiform activity. These results provide basic insights into the pattern of change in hippocampal neuronal activity during the development of the PTZ seizure model, and this in vivo electrophysiological seizure model could be used for future epilepsy studies.
